| 发明名称 |
Compound inhibiting activities of btk and/or jak3 kinases |
| 摘要 |
The present invention relates to a compound inhibiting the activities of Bruton’s tyrosine kinase (BTK) and/or Janus kinase 3 (JAK3), a pharmaceutical composition of the compound, pharmaceutical applications of same, a method for using the compound in inhibiting the activities of BTK and/or JAK3, and a method for using the compound in treatment and/or prevention of BTK- and/or JAK3-mediated diseases or disorders in mammals (especially human). The compound is as represented by structural formula (I). |
| 申请公布号 |
NZ718728(A) |
申请公布日期 |
2017.03.31 |
| 申请号 |
NZ20140718728 |
申请日期 |
2014.09.18 |
| 申请人 |
BEIJING HANMI PHARMACEUTICAL CO. LTD. |
发明人 |
Liu Jinming;Cha Mi Young;Li Gong;Li Zhanmei;Qiu Hongjuan;Kim Maengsup |
| 分类号 |
C07D487/04;A61K31/519;A61K31/53;A61K31/5377;A61P1/00;A61P7/02;A61P11/00;A61P17/06;A61P19/02;A61P29/00;A61P35/00;A61P37/02;C07D491/048;C07D495/04;C07D519/00 |
主分类号 |
C07D487/04 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
